{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:01:34Z","timestamp":1784894494939,"version":"3.55.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2026,7,22]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) is a key regulator of the pathogenesis of Alzheimer's\ndisease (AD), capable of simultaneously modulating core pathological processes such as\namyloid-\u03b2 (A\u03b2) deposition, tau protein hyperphosphorylation, synaptic damage, and neuroinflammation.\nTherefore, it has become one of the core druggable molecular nodes for AD intervention.\nThis review is mainly divided into two parts. The first part focuses on the GSK-3\u03b2 inhibitors that\nhave been validated in AD-related cell and animal models. These inhibitors are specifically classified\ninto four categories: metal ion-based compounds, adenosine triphosphate (ATP)-competitive\ninhibitors, non-ATP-competitive inhibitors, and multi-target inhibitors. The second part focuses on\nGSK-3\u03b2-specific positron emission tomography (PET) radioligands, which can non-invasively\nmonitor GSK-3\u03b2 enzyme activity in vivo, providing quantitative in vivo molecular imaging tracers\nfor the study of AD pathogenesis and quantitative assessment of treatment effects. This review\nsystematically summarizes GSK-3\u03b2-related inhibitors and PET radioligands in AD, thereby providing\nkey references for the rational design of next-generation AD therapeutic drugs and diagnostic\nagents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680266497019260720045602","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:10:42Z","timestamp":1784891442000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycogen Synthase Kinase-3\u03b2 in Alzheimer\u2019s Disease: Targets for Therapy\nand Imaging"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0929-7851","authenticated-orcid":true,"given":"Jianhua","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Radiological Medicine, College of Basic Medical Sciences, Chongqing Medical University,Chongqing 400016, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266497019260720045602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/256491\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266497019260720045602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:11:04Z","timestamp":1784891464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/256491\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266497019260720045602","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}